PSORS1C2: A Drug Target / Disease Biomarker (G170680)

Target Name: PSORS1C2

NCBI ID: G170680

PSORS1C2

PSORS1C2: A Drug Target / Disease Biomarker

PSORS1C2 is a protein that is expressed in the brain and is known for its role in the regulation of pain. It is a potential drug target for the treatment of chronic pain conditions such as osteoarthritis, cancer, and neurodegenerative diseases.

PSORS1C2 is a member of the PSOR family of proteins, which are known for their role in the regulation of pain signaling. The PSOR family includes several different proteins, including PSOR1, PSOR2, and PSOR6, which are expressed in various tissues throughout the body, including the brain.

PSORS1C2 is specifically expressed in the brain and is involved in the regulation of pain signaling in this organ. It is thought to play a role in the descending pain modulatory system, which is responsible for the inhibition of pain in the brain.

PSORS1C2 is also involved in the regulation of itch, which is a common symptom associated with various skin conditions. It is thought to contribute to the development and maintenance of itch, and may be a potential drug target for the treatment of skin conditions such as eczema and psoriasis.

In addition to its role in pain and itch regulation, PSORS1C2 is also involved in the regulation of inflammation. It is thought to contribute to the recruitment of immune cells to the site of inflammation, and may be a potential drug target for the treatment of inflammatory conditions such as rheumatoid arthritis and inflammatory bowel disease.

PSORS1C2 is also a potential biomarker for various diseases, including cancer. It is often used as a protein biomarker to evaluate the effectiveness of cancer therapies, and may be a useful diagnostic tool for the detection of cancer.

The PSOR family of proteins, including PSORS1C2, are of great interest to researchers because of their potential role in the regulation of pain and other biological processes. Many of these proteins have not yet been fully understood, and research is ongoing to determine their full function and potential as drug targets.

In conclusion, PSORS1C2 is a protein that is expressed in the brain and is involved in the regulation of pain and other biological processes. It is a potential drug target for the treatment of chronic pain conditions and may also be a useful biomarker for the detection of various diseases. Further research is needed to fully understand its role and potential as a drug and biomarker.

Protein Name: Psoriasis Susceptibility 1 Candidate 2

The "PSORS1C2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PSORS1C2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets